The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/32412
StudyName: Eligibility Squamous Cell Carcinoma NCT01009203
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 31.10.2018
License: Creative Commons BY 4.0

----

Description: 
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01009203
